Llorenç, Victor <br/><br/>
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.  [electronic resource] 

 -  Ophthalmology  06 2020 
 - 814-825 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2019.11.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--adverse effects<br/>Adult<br/>Anti-Inflammatory Agents--adverse effects<br/>Biological Therapy<br/>Drug-Related Side Effects and Adverse Reactions--diagnosis<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Registries--statistics & numerical data<br/>Retrospective Studies<br/>Spain<br/>Uveitis--diagnosis<br/>Withholding Treatment<br/>Young Adult